Researchers from Harvard Medical School in Boston exposed mice to various strains of a bacterium that causes a range of infections in those with weakened immune systems. Certain strains of the bacterium contained antibiotic-resistant genes, the same kind once thought to hinder the microbes. In this instance, the antibiotic-resistant strains were better than non-resistant strains at infecting the mice.
Resistant strains of bacteria that cause Acinetobacter baumannii, which is a known driver of hospital-acquired infections, were also better-equipped at infecting mice than those without resistant genes.
More articles on infection control:
Infection preventionists approve 11 C. diff prevention recommendations
15 stories on patient, workplace safety
‘Smart’ drug can target site-specific infections
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
